華領醫藥-B（02552.HK）股東結構 - 機構持倉、大股東與內部人士｜長橋證券

© 2026 Longbridge｜服務條款隱私政策

股東類型

公眾及其他64.81%
創投/私募28.14%
個人與內幕人士5.58%
機構投資者1.48%

主要股東

主要股東最新
股東
Arch Venture Partners, L.P.	12.55%	1.25 億	0.00%	+0	31/12/2025
VR Management, LLC	10.38%	1.03 億	0.00%	+0	31/12/2025
WuXi PharmaTech Healthcare Fund I General Partner L.P.	5.20%	5,180.76 萬	0.00%	+0	19/06/2025
Li ChenFounder, CEO, Member of Portfolio Advisory Board & Executive Director	4.07%	4,053.87 萬	0.08%	+75.00 萬	15/07/2026
Chien Cheng LinExecutive VP, Chief Strategy Officer & Executive Director	0.85%	849.93 萬	0.00%	+0	31/12/2025
Yi ZhangSenior VP of Pharma Development, Chief Medical Officer – China and Executive Director	0.64%	637.50 萬	0.00%	+0	31/12/2025
JP Morgan Asset Management	0.53%	524.40 萬	0.00%	+0	31/12/2025
E Fund Management Co., Ltd.	0.40%	398.52 萬	0.00%	+0	30/06/2025
State Street Investment Management	0.24%	241.30 萬	<0.01%	-4,000.00	31/07/2026
Dimensional Fund Advisors LP	0.16%	162.99 萬	0.00%	+0	31/07/2026
American Century Investment Management Inc	0.11%	110.10 萬	0.04%	+40.30 萬	31/07/2026
China Universal Asset Management Company Ltd.	0.03%	31.35 萬	0.00%	+0	31/12/2025
Robert Taylor NelsenNon-Executive Chairman	0.02%	15.00 萬	0.00%	+0	31/12/2025
Yiu Wa TsuiIndependent Non-Executive Director	<0.01%	2.40 萬	0.00%	+0	31/12/2025
Connor, Clark & Lunn Investment Management Ltd.	<0.01%	1.20 萬	0.00%	+0	31/12/2025
First Trust Advisors LP	0.00%	0.00	0.36%	-358.03 萬	30/06/2026